Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX)

CUSIP: 36338D108

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
75,462,362
Total 13F shares
9,781,540
Share change
-3,157,115
Total reported value
$1,369,942
Price per share
$0.14
Number of holders
35
Value change
-$464,165
Number of buys
12
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 36338D108?
CUSIP 36338D108 identifies GRTX - Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) as of Q1 2024

As of 31 Mar 2024, Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,781,540 shares. The largest 10 holders included GSA CAPITAL PARTNERS LLP, Blackstone Inc., abrdn plc, Nan Fung Group Holdings Ltd, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Atom Investors LP, UBS Group AG, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 35 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.